What is the cheapest GLP-1 medication without insurance in 2026?

Compounded semaglutide from telehealth providers like SkinnyRx starts at approximately $129/month. Among FDA-approved branded options, orforglipron is expected at ~$149/month and oral Wegovy starts at $199/month. Some uninsured patients qualify for free medication through manufacturer assistance programs.

Can I get Zepbound for $299 per month without insurance?

Yes, through LillyDirect as of March 2026. This pricing covers any dose (2.5mg through 15mg) and is confirmed through December 31, 2026. A valid prescription from a licensed provider is required.

Is compounded semaglutide safe to use?

Compounded semaglutide from a 503B outsourcing facility (FDA-inspected) has a reasonable safety track record. The main concerns are quality variability between providers and supply uncertainty due to ongoing FDA enforcement. Ask your provider which pharmacy type they use.

Do manufacturer patient assistance programs really provide free GLP-1 medications?

Yes. Novo Nordisk and Eli Lilly both offer assistance programs for uninsured patients earning below approximately 400% of the federal poverty level (~$60,000 for an individual). Processing takes 2–6 weeks. Most eligible patients never apply because they are unaware the programs exist.

Can I use an HSA or FSA to pay for GLP-1 medications?

Yes. GLP-1 medications prescribed for qualifying obesity (BMI 30+) or overweight with a comorbidity are HSA/FSA-eligible. Paying with pre-tax dollars effectively reduces cost by your marginal tax rate — typically 22–32%.

Insurance & Cost

Cheapest GLP-1 Without Insurance in 2026: Every Option Ranked by Price

Updated March 29, 2026

Fact Checked

You do not need insurance to access a GLP-1 in 2026. The cheapest options start at $129/month for compounded semaglutide, $149/month for orforglipron, and $199/month for oral Wegovy. Here is everything ranked and explained.

On this page

Cheapest GLP-1 Without Insurance in 2026: Every Option Ranked by Price

GLP-1 medications without insurance used to mean paying $1,000+ per month or going without. That has changed. In 2026, multiple pathways exist for patients without coverage to access GLP-1 therapy at $129–$299/month — and some patients qualify for $0 through assistance programs.

This guide covers every option available as of March 2026, ranked from cheapest to most expensive, with honest assessments of what you get and what you are giving up at each price point.

Medically reviewed by the Telehealth Ally Medical Review Team. Pricing and protocol data last verified March 2026.

Editorial Independence Note: Telehealth Ally does not accept payment from providers for placement or ranking. All pricing is independently researched. Revenue never influences our assessments. See our editorial policy for details.

Pricing Disclaimer: Prices shown reflect March 2026 data and may change. Compounded semaglutide in particular is subject to regulatory and market shifts that can affect availability and pricing. Confirm current pricing with the relevant provider before enrolling or making treatment decisions.

How We Evaluated GLP-1 Pricing Options

We evaluated every GLP-1 access pathway available to cash-pay patients across four criteria:

Clinical legitimacy. Is the medication FDA-approved or compounded? We distinguish between FDA-approved finished products (Wegovy, Zepbound, oral Wegovy, orforglipron) and compounded versions, noting regulatory status for each. Both categories are included, but the distinction is explicit.

Price transparency. We verified the actual monthly cost via each provider's checkout flow or manufacturer program page in March 2026 — total cost, not "starting at" marketing ranges. Where program fees and medication costs are separate, we calculated combined totals.

Accessibility and stability. How readily can a patient access this option today, and is supply or access at regulatory risk? Compounded options are assessed on regulatory stability alongside price.

Patient suitability. Income eligibility, insurance status, medical history, and medication preferences all factor into which option fits a given patient.

We have no commercial relationships with any medication manufacturer, pharmacy, or telehealth provider. Rankings are editorial-only.

Pricing last verified March 2026. We update pricing data monthly.

Quick Comparison: All Options Ranked by Monthly Cost

Option	Monthly Cost	Drug	FDA-Approved Product?	Notes
Manufacturer Patient Assistance	$0	Wegovy or Zepbound	Yes	Income-qualified uninsured patients only
Compounded semaglutide (telehealth)	$129–$199	Semaglutide	No (compounded)	Under active FDA scrutiny; availability uncertain
Orforglipron (LillyDirect)	~$149	Orforglipron	Pending	Oral pill; FDA approval expected around April 2026; anticipated lowest-cost branded option
Oral Wegovy — 4mg (Novo Direct)	$199	Semaglutide	Yes	Intro pricing expired Aug 31; now $199/mo for 4mg
GoodRx telehealth subscription + oral Wegovy	$199 + $39 sub fee	Semaglutide	Yes	$39/mo GoodRx membership unlocks $199 intro Wegovy/Ozempic price
Oral Wegovy — 9mg or 25mg (Novo Direct)	$299	Semaglutide	Yes	Full-dose tiers after initial titration
Zepbound self-pay (LillyDirect)	$299	Tirzepatide	Yes	Available through Dec 31, 2026; all doses same price
Walmart Zepbound (Lilly partnership)	$299	Tirzepatide	Yes	Same LillyDirect price, Walmart pharmacy fulfillment
TrumpRx	~$350	Brand injectables	Yes	New federal program; varies by drug and dose
Costco/retail pharmacy (injectable Wegovy)	~$499	Semaglutide	Yes	No club membership required for Costco pharmacy
Hims (authorized brand distributor)	Novo self-pay prices	Wegovy or Ozempic	Yes	Post-Novo settlement Mar 9, 2026; selling at Novo list prices

All prices as of March 2026. Always verify directly before enrolling.

What has changed about GLP-1 pricing in 2026?

Three developments have made GLP-1s more accessible for patients without insurance: oral pills at $149–$199/month, direct manufacturer pricing for Zepbound at $299/month, and ongoing FDA enforcement that is shifting the compounded semaglutide market. The result is a meaningfully different landscape than 2024.

The GLP-1 pricing landscape has shifted significantly in 2026. Three developments matter most for uninsured patients:

1. Oral pills are changing the calculus. Oral Wegovy and orforglipron (FDA approval expected around April 2026) are creating a sub-$200 tier for branded, FDA-approved GLP-1 therapy that did not exist a year ago. For patients who previously faced a choice between compounded injectables or paying $1,000+ for brand-name, a third path is emerging.

2. Compounded semaglutide is under meaningful regulatory pressure. The FDA has issued 30+ warning letters to compounding pharmacies in the February–March 2026 window. Compounded options remain available and are the cheapest entry point, but availability is not guaranteed, and patients should understand the risk of disruption.

3. Medicare coverage changed who "uninsured" actually means. If you are on Medicare, the calculus is different: brand-name Wegovy and Zepbound are expected to be available through Medicare Part D at approximately $50/month when the Bridge program launches July 1, 2026. If you are on Medicare and paying cash for compounded GLP-1s, you are likely overpaying significantly. This guide focuses primarily on patients without any insurance coverage, but the Medicare section below is worth reading if it applies to you.

Option 1: Manufacturer Patient Assistance — $0/Month

Who qualifies: Uninsured patients who meet income requirements — typically below 400% of the federal poverty level ($60,240 for an individual in 2026). These programs are means-tested and application-based.

Novo Nordisk Patient Assistance Program (Wegovy, Ozempic):

Provides brand-name semaglutide at no cost to qualifying uninsured patients
Apply through NovoCare (novocare.com) or ask your prescriber to initiate the application
Processing takes 2–6 weeks; short-term bridge supply may be available during review

Lilly Cares Foundation (Zepbound, orforglipron):

Provides brand-name tirzepatide or orforglipron at no cost to qualifying uninsured patients
Apply through LillyCares (lillycares.com) or through your prescribing physician
Annual recertification required

The catch: You need a prescriber willing to navigate the application process. Many telehealth providers — especially budget all-in platforms — do not assist with patient assistance applications. Providers like PlushCare, Ro, and Found are more likely to help, though you should ask directly.

Bottom line: If you are uninsured and your income falls below roughly $60,000 (individual), apply for manufacturer assistance before paying anything out of pocket. Most patients who qualify never apply because they do not know these programs exist.

Option 2: Compounded Semaglutide — $129–$199/Month

What it is: Semaglutide manufactured by third-party compounding pharmacies (not Novo Nordisk) and prescribed through telehealth platforms. The active ingredient is the same as Wegovy and Ozempic. The product is not FDA-approved as a finished drug.

Current pricing by provider:

Provider	Monthly Price	Includes
SkinnyRx	~$129	Medication, consultation, shipping
Henry Meds	~$149	Medication, consultation, shipping
Ro	~$149	Medication, consultation, messaging
Found	~$159	Medication, coaching, video visits
Noom	~$149	Medication, behavioral program
Hims (compounded)	~$199	Medication, consultation, shipping
Most others	$149–$199	Varies

Prices reflect the compressed $129–$199 market band as of March 2026. Outliers in either direction warrant scrutiny.

What you should know before choosing compounded semaglutide

The regulatory reality: The FDA declared the semaglutide shortage resolved in early 2025. That declaration removed the clearest legal basis for compounding — Section 503A of the Federal Food, Drug, and Cosmetic Act permits compounding of drugs in shortage. Since then, FDA enforcement has escalated, culminating in 30+ warning letters issued to compounding pharmacies in February–March 2026. As of March 2026, the legal status of compounded semaglutide remains contested in federal court, with different jurisdictions reaching different conclusions.

What this means practically: Compounded semaglutide is still available from the providers listed above. It may not be available indefinitely. If you start a compounded semaglutide program, identify a brand-name backup and understand your insurance or patient assistance options before you need them.

Quality varies. 503B outsourcing facilities (FDA-inspected, hospital-grade) generally offer more rigorous quality controls than 503A pharmacies (state-regulated). Ask your provider which type of pharmacy they source from. If they cannot answer clearly, consider that a signal.

What you are not getting: Insurance cannot cover compounded semaglutide. No manufacturer savings card applies. There is no path from compounded to insurance coverage without switching providers and starting a new prior authorization process.

Who compounded semaglutide makes sense for: Patients who want the lowest possible monthly cost today, who do not have insurance coverage for brand GLP-1s, and who understand and accept the regulatory uncertainty. It is a legitimate choice for many patients — just not one to make with incomplete information.

Option 3: Orforglipron (LillyDirect) — ~$149/Month

What it is: Orforglipron is Eli Lilly's oral GLP-1 receptor agonist awaiting FDA approval (PDUFA date April 10, 2026). Unlike semaglutide, orforglipron is a small-molecule pill — not a peptide — which means it does not require fasting or timing restrictions. It is taken once daily.

Pricing: Approximately $149/month through LillyDirect as of launch. This pricing was announced pre-approval and should be confirmed directly with LillyDirect, as introductory pricing can change.

Clinical context: In phase 3 trials, orforglipron produced approximately 11.2% body weight loss at 36 weeks. This is meaningfully lower than injectable semaglutide (~15% with Wegovy) and tirzepatide (~20% with Zepbound), but represents a real and clinically significant outcome for many patients. The convenience of a once-daily pill without fasting requirements is a genuine advantage for adherence.

Why it matters for uninsured patients: Orforglipron at ~$149/month announced would be the cheapest FDA-approved, branded GLP-1 option once available. It would undercut oral Wegovy by $50/month and be price-competitive with compounded semaglutide — while being a fully approved product with FDA manufacturing oversight.

Who it makes sense for: Patients who want a branded, regulated GLP-1 medication at the lowest possible price, who are comfortable with somewhat lower expected weight loss versus injectables, and who prefer a daily pill over weekly injections.

Insurance note: Orforglipron is not yet FDA-approved. Once approved, formulary placement will vary by plan. Check your plan's coverage after the FDA decision before assuming cash-pay is necessary.

Option 4: Oral Wegovy (Novo Direct) — $199–$299/Month

What it is: Oral semaglutide in the 50mg tablet formulation, FDA-approved specifically for weight management. This is brand-name Wegovy in pill form — manufactured by Novo Nordisk, not a compounding pharmacy.

Current pricing through NovoCare/Novo Direct:

Dose	Monthly Cost
4mg (starting/titration dose)	$199
9mg (titration)	$299
25mg (maintenance)	$299

Important context: Novo Nordisk ran an introductory self-pay price of $149/month through August 31, 2026. That pricing expired. The 4mg dose is now $199/month, and the 9mg and 25mg maintenance doses are $299/month. Patients who locked in the $149 price before August 31 should confirm whether their auto-refill pricing was preserved.

Efficacy: Clinical trials for oral semaglutide at 50mg demonstrated approximately 15% body weight loss — comparable to injectable Wegovy. The oral formulation has somewhat higher day-to-day absorption variability than the injectable, but in large trials the average efficacy was similar.

Administration note: Oral Wegovy requires specific administration — taken in the morning, at least 30 minutes before food or drink (water is allowed), with no more than 4oz of plain water. Missing this window reduces absorption. This is a genuine compliance consideration that some patients find challenging.

The pricing decision at $299/month for maintenance doses: At $299/month, oral Wegovy costs the same as Zepbound through LillyDirect. The choice then comes down to drug mechanism and efficacy expectations — tirzepatide generally produces greater weight loss in clinical data. Patients who prefer an oral option or have a clinical reason to use semaglutide may still choose oral Wegovy.

Option 5: Zepbound Self-Pay (LillyDirect) — $299/Month

What it is: Brand-name Zepbound (tirzepatide), the FDA-approved weight loss injection from Eli Lilly, purchased directly through LillyDirect without insurance.

Key details:

$299/month for any dose (2.5mg through 15mg — flat pricing regardless of dose)
This program is confirmed through December 31, 2026. Pricing beyond that has not been announced.
Requires a prescription from a licensed provider (your doctor or LillyDirect's telehealth partner)
Ships directly to your home
No insurance required, no prior authorization

Why this matters: Tirzepatide (the active ingredient in Zepbound and Mounjaro) is a dual GIP/GLP-1 receptor agonist with stronger average weight loss outcomes than GLP-1-only medications. Phase 3 SURMOUNT trials showed 18–22% average body weight loss, compared to roughly 15% with Wegovy. At the same $299/month price point as oral Wegovy's maintenance doses, the injectable format offers a potency advantage for patients whose primary goal is maximum weight loss.

The tradeoff: Weekly self-injection versus a daily pill. Some patients strongly prefer one; others are indifferent. Both are equally effective in terms of medication delivery when done correctly.

Walmart partnership: Lilly has a fulfillment partnership with Walmart pharmacy for Zepbound at the same $299/month price. If you prefer picking up at a pharmacy rather than home delivery, Walmart is the option.

Option 6: GoodRx Telehealth Subscription — $39/Month + $199/Month Medication

What it is: GoodRx now offers a telehealth subscription service ($39/month) that, among other benefits, provides access to brand Wegovy or Ozempic at an introductory self-pay price of $199/month.

Total monthly cost: $238/month for medication + subscription.

Why consider it: If you want brand-name injectable semaglutide (Wegovy or Ozempic) rather than the oral formulation, this pathway gets you there at $238/month combined — less than Zepbound through LillyDirect ($299/month) and less than injectable Wegovy at full retail.

What to verify: GoodRx telehealth pricing for GLP-1s has shifted several times in 2026. Confirm current subscription terms and medication pricing directly with GoodRx before enrolling. The $39/month fee continues whether or not you are actively filling a prescription.

Option 7: TrumpRx — ~$350/Month

What it is: TrumpRx is a federal executive initiative launched in 2026 aimed at reducing prescription drug costs for Americans. It operates as a reference pricing and purchasing program that targets certain high-cost medications, including brand-name GLP-1 injectables.

Pricing: Approximately $350/month for brand injectable GLP-1s (Wegovy, Zepbound) as of available data. Exact pricing varies by drug and dose, and program terms are evolving.

Important caveats: TrumpRx is a newer program and has been navigating implementation challenges. Formulary breadth, fulfillment, and program stability are all less proven than manufacturer direct programs. Verify current availability, supported drugs, and actual pricing directly before relying on this as your primary access pathway.

Who it may make sense for: Patients who want brand injectable GLP-1s and find $299–$350/month more accessible than retail pharmacy pricing, but who do not qualify for LillyDirect or prefer a different fulfillment model.

Option 8: Retail Pharmacy (Injectable Wegovy at Costco/Walmart) — ~$499/Month

What it is: Purchasing brand injectable Wegovy directly from a retail pharmacy without insurance.

Pricing: Approximately $499/month at Costco for injectable Wegovy, based on current cash-pay pricing. This is significantly below the ~$1,349/month list price but above manufacturer direct programs.

Note on Costco: Costco's pharmacy is open to non-members for prescription purchases. You do not need a Costco membership to use their pharmacy.

Why this option exists: Some patients prefer the familiarity of a retail pharmacy for filling prescriptions, have an existing prescriber who sends prescriptions to a local pharmacy, or are using GoodRx and other discount programs that work best with retail pharmacies. For those patients, Costco is among the lowest cash-pay retail options for injectable Wegovy.

The straightforward comparison: LillyDirect at $299/month for Zepbound (or $299/month for oral Wegovy maintenance) is cheaper than $499/month for injectable Wegovy at retail. If you are paying $499/month at a pharmacy for injectable Wegovy without insurance, there is almost certainly a lower-cost path for the same or equivalent medication.

Option 9: Hims (Authorized Brand Distributor) — Novo Self-Pay Prices

What it is: Following a settlement with Novo Nordisk announced March 9, 2026, Hims & Hers became an authorized distributor of brand Wegovy and Ozempic. Hims sells these medications at Novo Nordisk's established self-pay prices — not a discount on top, but the same prices you would get through NovoCare directly.

Pricing: Same as Novo Direct/NovoCare pricing — $199/month for oral Wegovy 4mg, $299/month for 9mg and 25mg.

Why choose Hims over going directly to Novo? Some patients may already have a Hims account and find it more convenient to manage everything through one platform. Hims also offers clinical support, messaging with providers, and prescription management that NovoCare does not. If you want brand semaglutide with wraparound clinical services and are comfortable with the Hims platform, it is a viable option at the same price point.

What to know: The Hims settlement represented a significant shift from their previous compounded semaglutide business. Their compounded program pricing was lower than their current brand pricing. Some existing Hims compounded semaglutide patients may have transitioned to higher-cost brand options under this arrangement — worth checking if you are a current Hims patient.

Is compounded semaglutide safe, and is it still legal?

Compounded semaglutide from a 503B outsourcing facility (FDA-inspected) has a reasonable safety track record, but the question "is compounded semaglutide legal" has a complicated answer in 2026 — it depends on who compounds it, for whom, and under what documented clinical need. The regulatory space is actively shrinking.

Price is one dimension. Regulatory status and manufacturing oversight are another. This section addresses them directly without advocacy in either direction.

What FDA approval means in practice

Brand-name GLP-1 medications (Wegovy, Zepbound, oral Wegovy, orforglipron) have been manufactured under FDA's full drug approval process:

Large-scale clinical trials demonstrating efficacy and safety in tens of thousands of patients
Current Good Manufacturing Practice (cGMP) standards at Eli Lilly and Novo Nordisk facilities
Lot-by-lot testing for potency, sterility, and purity
Post-market surveillance requirements

Compounded medications are not FDA-approved finished products. That does not mean they are unsafe — it means they are manufactured under a different, less uniform regulatory framework. The critical variables are:

503B outsourcing facilities are FDA-registered, subject to FDA inspection, and must meet cGMP standards. They are the closer analog to pharmaceutical manufacturing and generally considered higher quality within the compounding landscape.

503A compounding pharmacies are state-regulated, not federally inspected, and produce smaller batches. Quality controls vary more widely. The FDA has issued warning letters to 503A pharmacies citing issues including superpotent and subpotent formulations, non-sterile technique, and unapproved additives.

The 2026 FDA enforcement landscape

The 30+ warning letters issued to compounding pharmacies in February–March 2026 are not academic. They represent real actions against real operations and have led to voluntary production stops, recalls, and patient disruptions. Patients currently on compounded semaglutide from a provider whose pharmacy received a warning letter may have already experienced supply issues.

What we do not know: Whether FDA enforcement escalates to the point of meaningfully disrupting the broader compounded semaglutide market. Federal court cases contesting the FDA's shortage determination are ongoing. The regulatory trajectory is uncertain in both direction and timing.

The practical patient question

If cost is the primary concern and you are willing to accept regulatory uncertainty: compounded semaglutide at $129–$199/month is a real option for many patients. Discuss it with your prescribing provider; ask which pharmacy they use and whether it is a 503B facility; have a brand-name backup plan.

If regulatory certainty and FDA oversight are priorities — or if you are in a patient population where medication quality is especially critical (immunocompromised, complex comorbidities, elderly) — branded options at $149–$299/month are now close enough in price to compounded that the case for accepting regulatory uncertainty weakens.

Does Medicare cover GLP-1 weight loss medication?

Yes — Medicare Part D covers GLP-1 weight loss medications since April 1, 2026, and the Medicare Bridge program launches July 1, 2026, providing Wegovy and Zepbound at a $50/month maximum copay. If you are on Medicare, you are almost certainly overpaying by using compounded alternatives at $129–$199/month.

If you have any form of health insurance, this section applies to you even if you have never had GLP-1s covered before.

Medicare (if you are 65+ or on disability Medicare)

Medicare Part D GLP-1 coverage for weight management is scheduled to launch July 1, 2026 via the CMS Bridge program. The program is expected to cover Wegovy and Zepbound with a $50/month maximum copay. Reference price: $245/month (the announced benchmark for copay calculation).

If you are on Medicare and paying cash for a compounded GLP-1: You are almost certainly paying more than you need to. At $129–$199/month for compounded versus $50/month for brand-name Wegovy or Zepbound through Medicare, switching to your Medicare coverage is the financially rational move — with the added benefit of switching to an FDA-approved medication with better regulatory oversight.

To access Medicare coverage: confirm your Part D plan covers Wegovy or Zepbound for weight management (coverage is plan-dependent), get a prior authorization through your prescriber, and fill through your Part D plan's pharmacy.

For more detail, see our Medicare GLP-1 Coverage Guide.

Commercial insurance

If you have commercial insurance (employer-sponsored or ACA marketplace), check coverage before assuming you need to pay cash. Coverage for GLP-1s for weight management has expanded substantially:

Approximately 55–60% of large employer plans are expected to cover at least one GLP-1 for weight management by mid-2026 (up from prior years)
With the Wegovy savings card (for commercially insured patients whose plan covers it): $0–$25/month out of pocket
With the Zepbound savings card: $25/month out of pocket

The savings card programs are legitimate, substantial, and dramatically underutilized. A patient with commercial insurance who qualifies could reduce their cost from $199+/month to $25/month or less. Ten minutes on the phone with your insurer is worth the call.

To check coverage: call the pharmacy benefits number on the back of your insurance card. Ask specifically: "Is semaglutide covered for weight management (Wegovy)? Is tirzepatide covered for weight management (Zepbound)?"

For the full insurance navigation process, see our GLP-1 Prior Authorization Guide.

How do I find the cheapest way to get semaglutide online?

The cheapest way to get semaglutide online depends on your insurance status and what type of medication you are comfortable with. Work through these questions in order to find your best path.

Step 1: Are you on Medicare or Medicaid?

Medicare: Do not pay cash for GLP-1s. Wegovy and Zepbound are covered at $50/month max copay since July 1, 2026. See our Medicare coverage guide.

Medicaid: Coverage varies by state and has been expanding. Check your state Medicaid formulary before paying out of pocket. Some states cover GLP-1s at $0–$10/month copay.

Step 2: Do you have commercial insurance?

Call your insurer. If they cover Wegovy or Zepbound for weight management, you likely qualify for $25/month or less with a manufacturer savings card. This option beats everything else on this list on cost.

If they do not cover it yet, proceed to step 3.

Step 3: Do you meet income requirements for patient assistance?

If your income is below approximately $60,000/year (individual), apply to Novo Nordisk or Lilly Cares before paying anything. Free brand-name medication beats any paid option.

If you earn above that threshold or need medication immediately while waiting on applications, proceed to step 4.

Step 4: Do you want an oral pill or injectable?

If you prefer oral:

Orforglipron (~$149/month): Lowest-cost branded option, once-daily pill, no fasting required, ~11% weight loss
Oral Wegovy — 4mg ($199/month): Branded semaglutide pill, ~15% weight loss potential, requires 30-minute fasting window
Note: Oral options are appropriate for many patients but produce modestly less weight loss than injectable tirzepatide in head-to-head data

If you prefer injectable:

Compounded semaglutide ($129–$199/month): Cheapest injectable option; accept regulatory uncertainty, confirm 503B pharmacy
Zepbound/LillyDirect ($299/month): Brand injectable with strongest average weight loss data; flat pricing across all doses; confirmed through December 2026

Step 5: How important is weight loss magnitude to you?

If maximum weight loss is the priority and you are comfortable with injectables, Zepbound through LillyDirect at $299/month has the strongest clinical efficacy data of any self-pay option.

If lower cost is the priority and you accept some regulatory uncertainty, compounded semaglutide at $129–$199/month is a legitimate starting point.

If you want branded, FDA-approved medication at the lowest price, orforglipron at ~$149/month announced is expected to be the answer once it receives FDA approval (PDUFA April 10, 2026).

What should patients watch for in the next 6 months?

Several developments will reshape this landscape before the end of 2026:

LillyDirect Zepbound pricing beyond December 31, 2026: Eli Lilly has confirmed the $299/month self-pay price through year-end. What replaces it is not yet announced. Patients relying on LillyDirect cash-pay pricing should monitor for announcements in Q4 2026.

Compounded semaglutide court cases: At least two federal cases involving the FDA's authority over compounded semaglutide are expected to reach significant rulings before year-end. Outcomes could either stabilize or further disrupt compounded supply.

Orforglipron insurance coverage expansion: Once approved (PDUFA April 10, 2026), orforglipron will begin working through formulary negotiations with commercial insurers. By early 2027, some commercial plans will likely cover it, potentially bringing its insured copay below $149/month for some patients.

CagriSema (cagrilintide + semaglutide): If Novo Nordisk's next-generation combination therapy receives FDA approval in late 2026 as anticipated, it will add a premium tier above current options. Its pricing has not been announced; it is not expected to be a budget option.

Frequently Asked Questions

What is the cheapest GLP-1 medication available without insurance?

As of March 2026, compounded semaglutide from telehealth providers like SkinnyRx is the cheapest option at approximately $129/month. Among FDA-approved branded options, oral Wegovy starts at $199/month. Orforglipron is expected at approximately $149/month once it receives FDA approval (PDUFA April 10, 2026). These prices can change; verify current pricing before enrolling.

Is compounded semaglutide safe?

Compounded semaglutide from a reputable 503B outsourcing facility has a reasonable safety track record. The primary concerns are: (1) quality variability between providers — 503A pharmacies have less regulatory oversight than 503B facilities; and (2) supply uncertainty, as FDA enforcement actions have disrupted some compounding pharmacies. Ask your provider specifically which type of pharmacy they use. Compounded semaglutide is not identical to brand Wegovy — the regulatory status, manufacturing oversight, and formulation may differ.

Can I get Zepbound for $299/month without insurance?

Yes, through LillyDirect as of March 2026. This pricing is confirmed through December 31, 2026. You need a valid prescription from a licensed provider.

Is oral Wegovy as effective as injectable Wegovy?

In clinical trials, oral semaglutide 50mg (oral Wegovy) produced approximately 15% body weight loss, comparable to injectable Wegovy. The absorption is less consistent day-to-day with the oral formulation and requires strict timing (30 minutes before eating, with water only). For most patients the average efficacy is similar, but the compliance requirements differ. Discuss with your prescriber which formulation fits your lifestyle.

Is orforglipron as effective as Wegovy?

No, not on average. Orforglipron produced approximately 11.2% body weight loss in phase 3 trials; Wegovy produced approximately 15%. However, 11.2% weight loss is clinically meaningful for most patients with obesity, and orforglipron is easier to take (once daily, no fasting requirements) and cheaper. Whether the efficacy difference matters to you depends on your clinical goals.

Does Hims offer the cheapest brand semaglutide?

Hims sells brand Wegovy and Ozempic at Novo Nordisk's self-pay prices — the same pricing available through NovoCare directly. Hims is not cheaper than going to the source; it is equivalent. The reason to use Hims over NovoCare directly is clinical support and platform convenience, not pricing.

Can I use an HSA or FSA to pay for these?

Yes. GLP-1 medications prescribed for qualifying obesity or weight-related comorbidities (BMI ≥ 30, or BMI ≥ 27 with a comorbidity like hypertension or type 2 diabetes) are eligible HSA and FSA expenses. This does not reduce the sticker price, but paying with pre-tax dollars effectively reduces the cost by your marginal tax rate — typically 22–32% for most patients.

What happens if compounded semaglutide becomes unavailable?

If FDA enforcement or court rulings disrupt compounded semaglutide supply, your options become brand-name medications. If that happens, the relevant brand alternatives are oral Wegovy ($199–$299/month), orforglipron (~$149/month), and Zepbound through LillyDirect ($299/month). Having a backup plan — knowing whether you would qualify for insurance coverage or patient assistance, and which provider you would switch to — is worth working out before you need it.

What if I cannot afford any of these options?

Apply to manufacturer patient assistance programs before giving up. Novo Nordisk (NovoCare) and Lilly Cares provide free brand-name medication to qualifying uninsured patients at or below roughly 400% of the federal poverty level. These programs exist precisely for this situation. Your prescriber's office can often help initiate the application.

Sources

Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989–1002. (STEP 1 trial)
Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205–216. (SURMOUNT-1 trial)
FDA prescribing information: Wegovy (semaglutide injection 2.4 mg). Available at fda.gov. Accessed March 2026.
FDA prescribing information: Zepbound (tirzepatide injection). Available at fda.gov. Accessed March 2026.
LillyDirect self-pay pricing: $299/month for Zepbound (any dose), confirmed December 2026. lillyinsulin.com. Accessed March 2026.
NovoCare patient assistance: income eligibility up to ~400% federal poverty level. novocare.com. Accessed March 2026.
Provider pricing: verified via each provider's checkout flow or published pricing page, March 2026.

GLP-1 Telehealth Pricing Report Q2 2026 — Full pricing data across 30+ providers
Zepbound Price Guide 2026 — Every Zepbound pricing channel in detail
Oral Wegovy Complete Guide — How oral semaglutide works, dosing, efficacy, and who it is for
Orforglipron Complete Guide — Eli Lilly's new oral GLP-1 pill explained
Does Insurance Cover GLP-1 Medications? — Coverage by plan type, what to do if denied
Medicare GLP-1 Coverage Guide — Full breakdown of the new Medicare Part D benefit
Compounded Semaglutide: Legal and Safety Status 2026 — Regulatory timeline, court cases, what to watch
How to Save Money on GLP-1 Medications — Comprehensive cost-cutting strategies

Last verified: March 2026. Prices and program terms change frequently. Confirm current pricing directly with the relevant provider, pharmacy, or manufacturer before making treatment decisions. This guide is for informational purposes and does not constitute medical or financial advice.

Related Comparisons

Amazon Clinic vs Ro Health for GLP-1 Weight Loss: Big Tech vs Dedicated Program

Amazon Clinic vs Ro Health for GLP-1: retail giant pharmacy access vs dedicated weight loss program. Pricing, clinical depth, and medication access compared. April 2026.

Eden Health vs Ro for GLP-1: 2026 Comparison

Eden Health vs Ro compared side-by-side — flat-rate compounded pricing vs brand-name medications, and which GLP-1 provider fits your situation in 2026.

eMed vs Ro for GLP-1 Weight Loss: 2026 Comparison

eMed vs Ro compared side-by-side — smart scale, video consultations, and adherence tech vs Ro's streamlined brand-name GLP-1 approach. Pricing, clinical model, and who each fits.

Cheapest GLP-1 Without Insurance in 2026: Every Option Ranked by Price

Cheapest GLP-1 Without Insurance in 2026: Every Option Ranked by Price

How We Evaluated GLP-1 Pricing Options

Quick Comparison: All Options Ranked by Monthly Cost

What has changed about GLP-1 pricing in 2026?

Option 1: Manufacturer Patient Assistance — $0/Month

Option 2: Compounded Semaglutide — $129–$199/Month

What you should know before choosing compounded semaglutide

Option 3: Orforglipron (LillyDirect) — ~$149/Month

Option 4: Oral Wegovy (Novo Direct) — $199–$299/Month

Option 5: Zepbound Self-Pay (LillyDirect) — $299/Month

Option 6: GoodRx Telehealth Subscription — $39/Month + $199/Month Medication

Option 7: TrumpRx — ~$350/Month

Option 8: Retail Pharmacy (Injectable Wegovy at Costco/Walmart) — ~$499/Month

Option 9: Hims (Authorized Brand Distributor) — Novo Self-Pay Prices

Is compounded semaglutide safe, and is it still legal?

What FDA approval means in practice

The 2026 FDA enforcement landscape

The practical patient question

Does Medicare cover GLP-1 weight loss medication?

Medicare (if you are 65+ or on disability Medicare)

Commercial insurance

How do I find the cheapest way to get semaglutide online?

Step 1: Are you on Medicare or Medicaid?

Step 2: Do you have commercial insurance?

Step 3: Do you meet income requirements for patient assistance?

Step 4: Do you want an oral pill or injectable?

Step 5: How important is weight loss magnitude to you?

What should patients watch for in the next 6 months?

Frequently Asked Questions

What is the cheapest GLP-1 medication available without insurance?

Is compounded semaglutide safe?

Can I get Zepbound for $299/month without insurance?

Is oral Wegovy as effective as injectable Wegovy?

Is orforglipron as effective as Wegovy?

Does Hims offer the cheapest brand semaglutide?

Can I use an HSA or FSA to pay for these?

What happens if compounded semaglutide becomes unavailable?

What if I cannot afford any of these options?

Sources

Related Guides

Related Comparisons

Amazon Clinic vs Ro Health for GLP-1 Weight Loss: Big Tech vs Dedicated Program

Eden Health vs Ro for GLP-1: 2026 Comparison

eMed vs Ro for GLP-1 Weight Loss: 2026 Comparison

More Guides

Does Aetna Cover GLP-1 Medications? 2026 Coverage Guide

Aleniglipron: Structure Therapeutics' Oral GLP-1 — What Patients Need to Know

Amycretin (Zenagamtide): Novo Nordisk's Next-Gen GLP-1/Amylin Agonist

Best GLP-1 Medication 2026: Every Approved Option Ranked by Use Case

Which GLP-1 Has the Fewest Side Effects? A Medication-by-Medication Comparison

Best GLP-1 Options After Foundayo Approval: Oral vs Injectable 2026

Best GLP-1 Pill Options in 2026: Oral Wegovy, Orforglipron & More

Best Oral GLP-1 Options 2026: Foundayo vs Rybelsus Complete Comparison

Best GLP-1 Weight Loss Programs 2026: Every Major Provider Ranked

Best Growth Hormone Peptide Providers Online: 2026 Independent Comparison

Best Online HRT 2026: Telehealth Menopause Treatment Platforms Compared

Best Online TRT Clinics 2026: Telehealth Testosterone Replacement Compared

Best Oral GLP-1 Options in 2026: Every Pill Compared

Best Telehealth Providers for Tirzepatide 2026: Ranked by Price and Care

Best Weight Loss Injection 2026: Wegovy HD, Zepbound, and Every Option Compared

Best Weight Loss Medication 2026: Every FDA-Approved Option Ranked

Does Blue Cross Blue Shield Cover GLP-1 Medications? 2026 Guide

CagriSema Dosing Guide: Titration Schedule, Dose Steps & What to Expect

CagriSema Launch Day Patient Guide: What to Do Now That It's Here

CagriSema: The Semaglutide + Cagrilintide Combination — Patient Guide

CagriSema FDA Decision Guide: What to Expect and How to Prepare

CagriSema: What Patients Need to Know While the FDA Decision Drags On

CagriSema Side Effects: What Clinical Trials Show About Safety and Tolerability

Cheapest GLP-1 Without Insurance in 2026: Every Option Ranked by Price

CJC-1295 vs Ipamorelin: Complete Telehealth Comparison Guide 2026

CMS BALANCE Model Explained: Medicaid Obesity Care for 2026 and Beyond

Medicare GLP-1 Bridge Program: Implementation FAQ for Patients

Compounded GLP-1 Shutdown Timeline: From Shortage to Enforcement (2023–2026)

Is Compounded HRT Safe? What Patients Need to Know in 2026

Is Compounded Semaglutide Legal and Safe in 2026?

Compounded Tirzepatide 2026: What's Happening and What Patients Should Do

Contrave Guide 2026: How It Works, Weight Loss Results & How It Compares to GLP-1s

Does Insurance Cover GLP-1 Medications? Complete 2026 Guide

Does Insurance Cover Semaglutide? 2026 Coverage Guide